| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 02/04/1998 | CN1171960A Compound sophora flavescens injection |
| 02/04/1998 | CN1037266C Quinoline derivative fumarates and its preparing method and its medicinal composition |
| 02/03/1998 | US5714609 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 02/03/1998 | US5714588 Enhancement of cellular attachment using H3 protein |
| 02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
| 02/03/1998 | US5714491 Anticancer and antitumor agent |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714473 Chemotherapy; mixture with alkali metal citrate |
| 02/03/1998 | US5714328 RNA photocleavage using texaphyrins |
| 02/03/1998 | US5714148 Chemical compounds |
| 02/03/1998 | US5713828 Hollow-tube brachytherapy device |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 02/01/1998 | CA2184546A1 Method for treating pediatric high grade astrocytoma including brain stem glioma |
| 02/01/1998 | CA2184545A1 Cancer treatment with temozolomide |
| 01/29/1998 | WO1998003873A1 Treatment and diagnosis of cancer |
| 01/29/1998 | WO1998003654A2 High-affinity interleukin-4 muteins |
| 01/29/1998 | WO1998003573A1 Angiogenic inhibitory compounds |
| 01/29/1998 | WO1998003547A1 Antagonists of intestinotrophic glp-2 peptides |
| 01/29/1998 | WO1998003519A2 New bis-platinum complexes with polyamine ligands as antitumor agents |
| 01/29/1998 | WO1998003518A2 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
| 01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003458A1 Illudin analogs useful as antitumor agents |
| 01/29/1998 | WO1998003174A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |
| 01/29/1998 | CA2261162A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/28/1998 | EP0821068A2 Novel sphingolipids and a process thereto |
| 01/28/1998 | EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations |
| 01/28/1998 | EP0820998A2 Novel coumarin quinolone carboxylic acids and processes for the preparation thereof |
| 01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820985A1 Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/28/1998 | EP0820769A2 Use of benzothiophenes for the manufacture of a medicament for the treatment of diseases associated with an excess of tachykinis |
| 01/28/1998 | EP0820515A1 Phospholipase c homolog |
| 01/28/1998 | EP0820511A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 01/28/1998 | EP0820510A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors |
| 01/28/1998 | EP0820472A1 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 01/28/1998 | EP0820462A1 Cleavage of rna using metal complexes |
| 01/28/1998 | EP0820461A1 Chemical compounds |
| 01/28/1998 | EP0820452A1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase |
| 01/28/1998 | EP0820448A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
| 01/28/1998 | EP0820444A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 01/28/1998 | EP0820433A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 01/28/1998 | EP0820432A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 01/28/1998 | EP0820313A2 Radiolabeled peptides for diagnosis and therapy |
| 01/28/1998 | EP0820309A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 01/28/1998 | EP0820305A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
| 01/28/1998 | EP0820291A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 01/28/1998 | EP0820283A1 Lactacystin analogs |
| 01/28/1998 | EP0820282A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals |
| 01/28/1998 | EP0820281A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
| 01/28/1998 | EP0752886B1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/28/1998 | EP0715613B1 New diphenylhexene |
| 01/28/1998 | EP0641791B1 Novel benzothiophene derivative |
| 01/28/1998 | CN1171780A Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 01/28/1998 | CN1171743A Novel tumor suppressor gene HIC-1 |
| 01/28/1998 | CN1171265A Chinese-emdicinal pill for dispersing stasis |
| 01/28/1998 | CN1171254A Oral liquid for treating lung cancer and intestinal cancer and preparing process thereof |
| 01/28/1998 | CN1171242A Compound anticancer Chinese medicine |
| 01/28/1998 | CN1171241A Chinese herbal medicine composition for treating tumor and cancer |
| 01/28/1998 | CN1171238A Method for enhancing anticarcinogenic effect |
| 01/28/1998 | CN1037176C Benzenealkanoic acids for cardiovascular diseases |
| 01/27/1998 | US5712378 Sugar molecule is substituted with hydrocarbon or substituted hydrocarbon groups, antisense agents |
| 01/27/1998 | US5712377 Glycosides isolated from pollen, their sugar-free decomposition products and derivatives thereof |
| 01/27/1998 | US5712307 Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof |
| 01/27/1998 | US5712305 Antineoplastic cocoa extracts and methods for making and using the same |
| 01/27/1998 | US5712300 Hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712280 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 01/27/1998 | US5712273 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 01/27/1998 | US5712260 Estramustine formulations with improved pharmaceutical properties |
| 01/27/1998 | US5712155 DNA encoding tumor necrosis factor-α and -β receptors |
| 01/27/1998 | US5712129 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 01/27/1998 | US5712120 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 01/27/1998 | US5712104 Screening test for cancer, aids/hiv, influenza |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/27/1998 | CA2015632C Stable solutions of rebeccamycin analog and preparations thereof |
| 01/27/1998 | CA1339646C Neplanocin derivatives |
| 01/27/1998 | CA1339644C Method of preparing beta-2',2'-difluoronucleosides |
| 01/26/1998 | CA2210448A1 Novel coumarin quinolone carboxylic acids and processes for the preparation thereof |
| 01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | WO1998002539A1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 01/22/1998 | WO1998002538A1 Melanoma associated peptide analogues and vaccines against melanoma |
| 01/22/1998 | WO1998002529A1 Highly productive packaging lines |
| 01/22/1998 | WO1998002525A1 Pituitary differentiation factor and methods of use thereof |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
| 01/22/1998 | WO1998002446A1 Morpholinyl anthracycline derivatives |
| 01/22/1998 | WO1998002438A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002437A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | WO1998002434A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002163A1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1998002038A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |